Get the Stockscreener App
5.75
1.23%
0.07
Reshape Lifesciences Inc stock is traded at $5.75, with a volume of 30,477.
It is up +1.23% in the last 24 hours and up +4.93% over the past month.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
See More
Previous Close:
$5.68
Open:
$5.73
24h Volume:
30,477
Relative Volume:
0.14
Market Cap:
$3.98M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.0898
EPS:
-64.04
Net Cash Flow:
$-17.45M
1W Performance:
+14.09%
1M Performance:
+4.93%
6M Performance:
-47.27%
1Y Performance:
-55.14%
1-Day Range:
$5.49
$5.76
1-Week Range:
$4.98
$5.8819
52-Week Range:
$4.60
$34.22
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Name
Reshape Lifesciences Inc
Sector
Industry
Phone
949-429-6680
Address
1001 CALLE AMANECER, SAN CLEMENTE
Compare RSLS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
5.75 | 3.98M | 9.81M | -26.16M | -17.45M | -64.04 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Reshape Lifesciences Inc Stock (RSLS) Latest News
Weight-Loss Devices Market Will Drive an Exponential CAGR - openPR
Intragastric Balloons Market Size to Surpass USD 160.7 - GlobeNewswire
Earnings call: ReShape Lifesciences reports growth and strategic mergers - Investing.com
Earnings call: ReShape Lifesciences reports growth and strategic mergers By Investing.com - Investing.com Canada
ReShape Lifesciences Inc (RSLS) Quarterly 10-Q Report - Quartzy
ReShape Lifesciences Reports Q3 Growth and Strategic Moves - TipRanks
ReShape Lifesciences® Reports Third Quarter Ended September - GlobeNewswire
ReShape Lifesciences Reports 16.6% Revenue Growth, Inks $5.16M Asset Sale Deal | RSLS Stock News - StockTitan
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update - The Manila Times
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and - The Bakersfield Californian
Gastric Electrical Stimulators Market Size, Share and Growth - openPR
Health Canada approves ReShape's Lap-Band 2.0 FLEX By Investing.com - Investing.com Australia
ReShape Lifesciences® to Announce Financial Results for the - GlobeNewswire
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - The Manila Times
FibroGen Reports Third Quarter 2024 Financial Results - The Manila Times
ReShape Lifesciences (RSLS) Sets Q3 2024 Earnings Call with Post-Merger Chairman | RSLS Stock News - StockTitan
ReShape secures NIH grant to develop electrodes for diabetes treatment device - Medical Device Network
Health Canada approves ReShape's Lap-Band 2.0 FLEX - Investing.com
ACNB Corporation Receives Regulatory Approvals to Acquire Traditions Bancorp, Inc. - The Manila Times
Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX - GlobeNewswire
ReShape's Lap-Band 2.0 FLEX Secures Health Canada Approval, Expands Market Reach | RSLS Stock News - StockTitan
Next-Generation Diabetes-Managing Innovations - Trend Hunter
Banzai Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement - The Manila Times
ReShape Lifesciences receives NIH supplementary grant with CARSS - TipRanks
ReShape Lifesciences® Receives NIH Supplementary Grant with - GlobeNewswire
ReShape Lifesciences Secures $241K NIH Grant for Breakthrough Diabetes Device Development | RSLS Stock News - StockTitan
Inuvo Reports 23% Sequential Revenue Growth in Q3 2024On November 8, 2024, Inuvo, Inc. (NYSE American: INUV) released its financial performance for the third quarter of 2024, showcasing a substantial 23% sequential revenue increase to $22.4 million c - Defense World
Enphase Energy Inc (ENPH-Q) QuotePress Release - The Globe and Mail
Johnson & Johnson (JNJ-N) QuotePress Release - The Globe and Mail
Brookfield Asset Management Ltd (BAM-N) QuotePress Release - The Globe and Mail
(RSLS) Technical Pivots with Risk Controls - Stock Traders Daily
Qualcomm Inc (QCOM-Q) QuotePress Release - The Globe and Mail
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SOI, RS - GuruFocus.com
(RSLS) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail
What's Driving These Stocks Higher In After-hours? - RTTNews
Objective long/short (RSLS) Report - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) Stock Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Weight-Loss Devices Market 2024: Global Segmentation Trends, - openPR
ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 472.0% in September - MarketBeat
Implantable Pulse Generator Market Report 2024: Size, Share, Growth, Forecast to 2033 - WhaTech
Gastric Electrical Stimulators Market will attempt to create - openPR
ReShape Lifesciences Enters Into A Merger Agreement With Vyome Therapeutics - MPO-mag
How to Take Advantage of moves in (RSLS) - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
RSLS stock touches 52-week low at $4.99 amid market challenges - Investing.com
Bariatric Surgery Devices Global Market Research 2024-2033: Outlook and Overview - WhaTech
ReShape Lifesciences (OTCMKTS:RSLSD) Trading Up 2.3% - Defense World
Trend Tracker for (RSLS) - Stock Traders Daily
ReShape Lifesciences (NASDAQ:RSLS) and Sintx Technologies (NASDAQ:SINT) Head to Head Analysis - Defense World
Reshape Lifesciences Inc Stock (RSLS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):